TAYLOR BEN R (Chief Financial Officer) sold 1.1% of their position (13.43K shares) of RECURSION PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $41.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/19/2026ACC: 0001601830-26-000020
Officer· Chief Financial Officer
Since Feb 2026
-25.33K
Net shares
Net seller
$82.9K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
25.33K disposed
Non-Derivative Transactions2
Class A Common Stock
Direct
Shares
−11.91K
Price / share
$3.49
Trade value
$41.56K
% of position
1.0%
2/17/2026
1.22M→1.21M
Class A Common Stock
Direct
Shares
−13.43K
Price / share
$3.08
Trade value
$41.35K
% of position
1.1%
2/18/2026
1.21M→1.20M
Total
Net shares
−25.33K
Net value
-$82.91K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 2/17/2026 | F · Tax Withholding | −11.91K | $3.49 | $41.56K | 1.0% | 1.22M | 1.21M |
| Class A Common Stock Direct | 2/18/2026 | S · Sale | −13.43K | $3.08 | $41.35K | 1.1% | 1.21M | 1.20M |
| Total | −25.33K | -$82.91K | ||||||
Derivative Transactions0
No derivative transactions reported